Victory Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-689,603
| Closed | -$16.3M | – | 2603 |
|
|
2023
Q4 | $16.3M | Sell |
689,603
-347,830
| -34% | -$6.19M | 0.02% | 853 |
|
|
2023
Q3 | $15.5M | Buy |
1,037,433
+988,683
| +2,028% | +$13.1M | 0.02% | 849 |
|
|
2023
Q2 | $534K | Buy |
48,750
+38,673
| +384% | +$360K | ﹤0.01% | 1952 |
|
|
2023
Q1 | $87.9K | Buy |
+10,077
| New | +$80.7K | ﹤0.01% | 2376 |
|
|
2021
Q4 | – | Sell |
-42,448
| Closed | -$155K | – | 2871 |
|
|
2021
Q3 | $155K | Hold |
42,448
| – | – | ﹤0.01% | 2567 |
|
|
2021
Q2 | $185K | Sell |
42,448
-27,994
| -40% | -$124K | ﹤0.01% | 2542 |
|
|
2021
Q1 | $320K | Sell |
70,442
-2,773
| -4% | -$14.9K | ﹤0.01% | 2372 |
|
|
2020
Q4 | $420K | Buy |
73,215
+22,661
| +45% | +$172K | ﹤0.01% | 2158 |
|
|
2020
Q3 | $366K | Sell |
50,554
-22,258
| -31% | -$119K | ﹤0.01% | 2086 |
|
|
2020
Q2 | $254K | Sell |
72,812
-72,812
| -50% | -$210K | ﹤0.01% | 2231 |
|
|
2020
Q1 | $216K | Buy |
145,624
+68,646
| +89% | +$115K | ﹤0.01% | 2312 |
|
|
2019
Q4 | $151K | Hold |
76,978
| – | – | ﹤0.01% | 2390 |
|
|
2019
Q3 | $394K | Buy |
76,978
+75,700
| +5,923% | +$458K | ﹤0.01% | 1975 |
|
|
2019
Q2 | $9K | Hold |
1,278
| – | – | ﹤0.01% | 1813 |
|
|
2019
Q1 | $17K | Hold |
1,278
| – | – | ﹤0.01% | 1750 |
|
|
2018
Q4 | $10K | Sell |
1,278
-244
| -16% | -$2.32K | ﹤0.01% | 1767 |
|
|
2018
Q3 | $17K | Buy |
1,522
+200
| +15% | +$2.48K | ﹤0.01% | 1766 |
|
|
2018
Q2 | $18K | Buy |
+1,322
| New | +$16.5K | ﹤0.01% | 1800 |
|